Long-Term Outcomes of Epidural Motor Cortex Stimulation for Refractory Chronic Neuropathic Orofacial Pain
Life · 12.04.2026 · 16 (4) · 651
DOI: 10.3390/life16040651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 12.04.2026. Verfasst von Marina Raguž und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Dubrava University Hospital, 10000 Zagreb, Croatia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERDF fund.
Abstract (Originalsprache)
Background
Epidural motor cortex stimulation (MCS) is an established neuromodulatory option for refractory neuropathic pain; however, structured data on long-term outcomes, stimulation dependency, and real-world device management remain limited, particularly in chronic neuropathic orofacial pain.
Methods
This retrospective single-center cohort study included patients with refractory neuropathic orofacial pain treated with epidural MCS at a tertiary neurosurgical center. Clinical data were extracted from medical records and longitudinal follow-up documentation. Pain intensity was assessed using a unified 0–10 numerical rating scale (NRS/VAS) at baseline, best achieved response, and last follow-up. Responder status was defined at the last follow-up (≥50% pain reduction from baseline). Secondary outcomes included stimulation dependency during OFF periods, reprogramming burden, device-related events, and safety.
Results
Ten patients (6 women, 4 men; mean age 61.5 ± 8.6 years) were followed for a mean of 7.6 ± 6.3 years (range 2–22 years), with 70% exceeding five years of follow-up. Baseline pain intensity (8.8 ± 0.4) decreased to 4.6 ± 0.8 at the best achieved response and remained lower at last follow-up (5.6 ± 0.9). At the last follow-up, eight patients (80%) were classified as partial responders (30–49% pain reduction), while two (20%) were classified as non-responders. Clinically relevant worsening during stimulator OFF periods occurred in 70% of patients. Reprogramming was required in all patients, and 60% underwent battery replacement. No clinically significant stimulation-related adverse effects were observed.
Conclusions
Epidural MCS was associated with sustained pain reduction over extended follow-up. These findings support the interpretation of MCS as a chronic neuromodulatory therapy requiring ongoing stimulation, individualized programming, and long-term device management, contributing clinically relevant long-term evidence to the evolving role of neuromodulation in refractory chronic neuropathic pain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Dubrava University Hospital, 10000 Zagreb, Croatia.
- School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia.
- Department of Maxillofacial Surgery, Dubrava University Hospital, 10000 Zagreb, Croatia.
- School of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia.
- Medicine of Sports and Exercise Chair, Faculty of Kinesiology, University of Zagreb, 10000 Zagreb, Croatia.
- School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
ORCID-Profile: Marina Raguž, Marko Tarle, Sven Krušić
Förderung
- ERDF fund
Zitieren
APA
Raguž, M., Tarle, M., Marčinković, P., Krušić, S., Dlaka, D., Marinović, T., & Chudy, D. (2026). Long-Term Outcomes of Epidural Motor Cortex Stimulation for Refractory Chronic Neuropathic Orofacial Pain. Life, 16(4), 651. https://doi.org/10.3390/life16040651
Vancouver
Raguž M, Tarle M, Marčinković P, Krušić S, Dlaka D, Marinović T, et al. Long-Term Outcomes of Epidural Motor Cortex Stimulation for Refractory Chronic Neuropathic Orofacial Pain. Life. 2026;16(4):651. doi:10.3390/life16040651
BibTeX
@article{Ragu2026,
author = {Raguž, Marina and Tarle, Marko and Marčinković, Petar and Krušić, Sven and Dlaka, Domagoj and Marinović, Tonko and Chudy, Darko},
title = {Long-Term Outcomes of Epidural Motor Cortex Stimulation for Refractory Chronic Neuropathic Orofacial Pain},
journal = {Life},
year = {2026},
volume = {16},
number = {4},
pages = {651},
doi = {10.3390/life16040651}
}
EUVIMED